How much dividend does I-Mab pay?
Over the past 12 months, I-Mab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, I-Mab is expected to pay a dividend of 0 USD.
I-Mab Dividend 2025
I-Mab Dividend
0 USD
I-Mab Dividend yield
Ticker
IMAB
ISIN
US44975P1030
WKN
A2PVC6
How much dividend does I-Mab 2025 pay?
According to the latest status from October 2025, I-Mab paid a total of 0 USD per share in dividends within the last 12 months. With the current I-Mab price of 6.91 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical I-Mab Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the I-Mab Dividend Safe?
I-Mab has been increasing the dividend for 0 years.
Over the past 8 years, I-Mab has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding I-Mab's Dividend Distributions
I-Mab’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining I-Mab's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
I-Mab's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in I-Mab’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
I-Mab Aktienanalyse
What does I-Mab do?
I-Mab is a Chinese biopharmaceutical company specializing in the development of innovative therapies for the treatment of cancer and autoimmune diseases. It was founded in 2016 by Dr. Jingwu Zang and is based in Shanghai, China. I-Mab's business model focuses on the development of antibody therapies tailored to the needs of cancer and autoimmune patients. They utilize the latest research and development to create therapies that address the unmet market demand. They work on cancer immunotherapy, including CAR-T cell therapy, and also on immunotherapy for autoimmune diseases, including rare ones. Their goal is to improve the lives of patients with cancer and autoimmune diseases through innovative biotechnology and research. They have promising products in development and clinical trials, such as AMG 228 and TJM2. They aim to make a significant contribution to healthcare with their dedicated team of researchers and scientists. I-Mab is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about I-Mab stock
What is the dividend yield of I-Mab?
The current dividend yield of I-Mab is .
When does I-Mab pay dividends?
I-Mab pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of I-Mab?
I-Mab paid dividends every year for the past 0 years.
What is the dividend of I-Mab?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is I-Mab located?
I-Mab is assigned to the 'Health' sector.
Wann musste ich die Aktien von I-Mab kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of I-Mab from 10/17/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/17/2025.
When did I-Mab pay the last dividend?
The last dividend was paid out on 10/17/2025.
What was the dividend of I-Mab in the year 2024?
In the year 2024, I-Mab distributed 0 USD as dividends.
In which currency does I-Mab pay out the dividend?
The dividends of I-Mab are distributed in USD.
Andere Kennzahlen von I-Mab
Our stock analysis for I-Mab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of I-Mab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
